Abstract
There is currently no effective treatment for the devastating muscle-wasting disease Duchenne muscular dystrophy (DMD). Cossu and colleagues report in a recent Nature paper that transplantation of mesoangioblast stem cells may hold promise for treating DMD. Further studies are required to fully evaluate the clinical potential of these blood-vessel-associated stem cells.
Original language | English |
---|---|
Pages (from-to) | 1304-1306 |
Journal | Cell |
Volume | 127 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2006 |